You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

72 search results for: type 2 inflammation

expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

42 min

Dermatology

In this ADVENT symposium at the 2024 Diversity in Dermatology conference, experts Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.

expert video

Comorbidities in Children and Adolescents with Atopic Dermatitis

14 min

Dermatology

Join Dr. Siegfried as she discusses comorbidities in children and adolescents with AD

Mechanisms of Pruritus in AD & PN: Role of <b>Type</b> <b>2</b> <b>Inflammation</b>

expert video

Mechanisms of Pruritus in AD & PN: Role of Type 2 Inflammation

20 min

Dermatology

Neuroimmune mechanisms of chronic pruritus in atopic dermatitis and prurigo nodularis – Clip from the ADVENT symposium at AAD 2023.

expert video

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features

10 min

Pulmonology

Dr Igor Barjaktarevic discusses the role of underlying inflammation in COPD pathology and associated clinical features and explore the importance of biomarker assessments and endotyping in COPD

ERS <b>2</b>0<b>2</b>3 | The Impact of <b>Type</b> <b>2</b> <b>Inflammation</b> on COPD: Examining Its Role in Disease Pathophysiology

expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

17 min

Pulmonology

Prof. Klaus Rabe and Dr. Stephanie Christenson explore COPD's clinical presentation through disease pathology, emphasizing its diverse inflammatory pathways.

Learn more about how dysregulated type 2 inflammation contributes to polymorphous lesions and dermal epidermal splitting in bullous pemphigoid

Infographic

Bullous Pemphigoid (BP) Pathophysiology Infographic

4 min

Dermatology

A static infographic detailing how autoimmunity and Type 2 inflammation play a critical role in the pathophysiology of Bullous Pemphigoid (BP).

expert video

Type 2 Inflammation at the Neuroimmune Axis in PN and CSU

2 min

Dermatology

Dr. Elmariah discusses and illustrates the overlapping and distinct roles of type 2 cytokines at the neuroimmune axis in PN and CSU

expert video

Expert Interview: Inflammatory Cell Infiltrate and Type 2 Inflammation in PN and CSU

2 min

Dermatology

Dr. Metz describes the inflammatory cell infiltrate seen in PN and CSU and how inflammatory cells in the skin contribute to a type 2 inflammatory environment.

EoE: A Chronic, Progressive, <b>Type</b> <b>2</b> Inflammatory Disease

Infographic

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease

5 min

Gastroenterology

Learn about key drivers of type 2 inflammation in EoE and how they mediate progressive esophageal remodeling and impact patient burden.

Infographic

Adult Lung Function Static Infographic

5 min

Pulmonology

Review this infographic on lung function

interactivity

Why Is It Important to Assess Lung Function in Pediatric Asthma

5 min

Pulmonology

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma

Unique and Overlapping Roles of <b>Type</b> <b>2</b> Cytokines in AD and PN

expert video

Unique and Overlapping Roles of Type 2 Cytokines in AD and PN

1 min

Dermatology

Explore the unique and shared roles of type 2 cytokines in atopic dermatitis and prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region